Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MASIMO CORP Director's Dealing 2025

Mar 13, 2025

30755_dirs_2025-03-12_91a5bf71-4503-4c6b-ade0-a20862d31240.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MASIMO CORP (MASI)
CIK: 0000937556
Period of Report: 2025-03-10

Reporting Person: Muhsin Bilal (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-10 Common Stock M 30000 $37.84 Acquired 54172 Direct
2025-03-10 Common Stock S 2400 $163.28 Disposed 51772 Direct
2025-03-10 Common Stock S 3935 $165.18 Disposed 47837 Direct
2025-03-10 Common Stock S 10087 $166.03 Disposed 37750 Direct
2025-03-10 Common Stock S 1436 $166.71 Disposed 36314 Direct
2025-03-10 Common Stock S 1700 $167.97 Disposed 34614 Direct
2025-03-10 Common Stock S 1761 $169.37 Disposed 32853 Direct
2025-03-10 Common Stock S 6965 $170.86 Disposed 25888 Direct
2025-03-10 Common Stock S 1716 $171.76 Disposed 24172 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-10 Non-Qualified Stock Option (Right to Buy) $37.84 M 30000 Disposed 2026-02-28 Common Stock (30000) Direct

Footnotes

F1: Sales were effected in transactions intended to satisfy the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2: The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $162.99 per share to a high of $163.80 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $164.62 per share to a high of $165.61 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $165.62 per share to a high of $166.61 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $166.62 per share to a high of $166.89 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $170.47 per share to a high of $171.43 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F7: The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $171.47 per share to a high of $172.46 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F8: This option was granted on February 29, 2016 and was exercisable as the option vested. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.